DAFNA Capital Management LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 218 filers reported holding SAGE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$8,477,988
+12.1%
180,3060.0%2.32%
+2.2%
Q1 2023$7,565,640
+10.0%
180,3060.0%2.27%
+17.1%
Q4 2022$6,876,871
-2.6%
180,3060.0%1.94%
+2.0%
Q3 2022$7,061,000
+21.2%
180,3060.0%1.90%
+19.7%
Q2 2022$5,824,000
-2.4%
180,3060.0%1.59%
+2.1%
Q1 2022$5,968,000
-22.2%
180,3060.0%1.56%
-19.4%
Q4 2021$7,670,000
-4.0%
180,3060.0%1.93%
-9.0%
Q3 2021$7,989,000
-17.4%
180,306
+5.9%
2.12%
+4.8%
Q2 2021$9,675,000
-28.7%
170,306
-6.1%
2.02%
-37.2%
Q1 2021$13,571,000
-13.5%
181,3060.0%3.22%
-31.0%
Q4 2020$15,685,000
+62.1%
181,306
+14.5%
4.67%
+48.4%
Q3 2020$9,676,000
+40.8%
158,306
-4.2%
3.14%
+58.6%
Q2 2020$6,873,000
+44.8%
165,3060.0%1.98%
+0.1%
Q1 2020$4,748,000
-47.3%
165,306
+32.5%
1.98%
-36.0%
Q4 2019$9,010,000
-48.5%
124,8060.0%3.09%
-53.0%
Q3 2019$17,509,000
-22.8%
124,806
+0.8%
6.58%
-22.7%
Q2 2019$22,668,000
+15.1%
123,8060.0%8.52%
+0.3%
Q1 2019$19,691,000
+97.1%
123,806
+18.7%
8.50%
+71.0%
Q4 2018$9,991,000
-28.8%
104,306
+5.0%
4.97%
-13.8%
Q3 2018$14,027,000
-6.7%
99,306
+3.4%
5.76%
-18.1%
Q2 2018$15,027,000
-0.8%
96,000
+2.1%
7.04%
-4.5%
Q1 2018$15,141,000
+219.2%
94,000
+226.4%
7.37%
+188.3%
Q4 2017$4,744,00028,8002.56%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 409,000$17,399,0004.82%
Palo Alto Investors LP 781,730$33,255,0002.12%
DAFNA Capital Management LLC 180,306$7,670,0001.93%
Boxer Capital, LLC 1,094,000$46,539,0001.81%
Deep Track Capital, LP 500,000$21,270,0001.50%
Bellevue Group AG 3,228,004$137,319,0001.42%
EcoR1 Capital, LLC 940,636$40,015,0001.28%
Deep Track Capital, LP 400,000$17,016,0001.20%
Artal Group S.A. 1,000,000$42,540,0001.15%
SECTOR GAMMA AS 98,904$4,207,0000.99%
View complete list of SAGE THERAPEUTICS INC shareholders